Knowledge‐based structural models of SARS‐CoV‐2 proteins and their complexes with potential drugs

The World Health Organization (WHO) has declared the coronavirus disease 2019 (COVID‐19) caused by the novel coronavirus SARS‐CoV‐2 a pandemic. There is, however, no confirmed anti‐COVID‐19 therapeutic currently. In order to assist structure‐based discovery efforts for repurposing drugs against this disease, we constructed knowledge‐based models of SARS‐CoV‐2 proteins and compared the ligand molecules in the template structures with approved/experimental drugs and components of natural medicines. Our theoretical models suggest several drugs, such as carfilzomib, sinefungin, tecadenoson, and trabodenoson, that could be further investigated for their potential for treating COVID‐19.

[1]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[2]  L. Carpenter,et al.  S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research. , 2017, The Journal of clinical psychiatry.

[3]  R. Natesh,et al.  Crystal structure of the human angiotensin-converting enzyme–lisinopril complex , 2003, Nature.

[4]  D. Alland,et al.  The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing , 2017, mBio.

[5]  E. Sturrock,et al.  Molecular and Thermodynamic Mechanisms of the Chloride-dependent Human Angiotensin-I-converting Enzyme (ACE)* , 2013, The Journal of Biological Chemistry.

[6]  Christopher J. Williams,et al.  MolProbity: More and better reference data for improved all‐atom structure validation , 2018, Protein science : a publication of the Protein Society.

[7]  S. de Lusignan,et al.  Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data , 2019, PLoS medicine.

[8]  B. Cowling,et al.  Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network , 2016, PloS one.

[9]  M. Antonelli,et al.  Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. , 2009, JAMA.

[10]  A. Garcia-Basteiro,et al.  The Good, the Bad and the Ugly of the Next-Generation Xpert Mtb/Rif® Ultra Test for Tuberculosis Diagnosis. , 2017, Archivos de bronconeumologia.

[11]  J. Macneil,et al.  High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine , 2017, MMWR. Morbidity and mortality weekly report.

[12]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[13]  Guangdi Li,et al.  Therapeutic options for the 2019 novel coronavirus (2019-nCoV) , 2020, Nature Reviews Drug Discovery.

[14]  Quan Liu,et al.  First isolation and characterization of Getah virus from cattle in northeastern China , 2019, BMC Veterinary Research.

[15]  Lisa E. Gralinski,et al.  Return of the Coronavirus: 2019-nCoV , 2020, Viruses.

[16]  Shigeki Mitaku,et al.  SOSUI: classification and secondary structure prediction system for membrane proteins , 1998, Bioinform..

[17]  Wu Zhong,et al.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.

[18]  M. Rattray,et al.  Cytokine Responses to Rhinovirus and Development of Asthma, Allergic Sensitization, and Respiratory Infections during Childhood , 2018, American journal of respiratory and critical care medicine.

[19]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[20]  D. Falzarano,et al.  SARS and MERS: recent insights into emerging coronaviruses , 2016, Nature Reviews Microbiology.

[21]  Bruno Canard,et al.  In Vitro Reconstitution of SARS-Coronavirus mRNA Cap Methylation , 2010, PLoS pathogens.

[22]  Y. Kanno,et al.  Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. , 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[23]  M. Schapira,et al.  Structure-based view of the druggable genome. , 2020, Drug discovery today.

[24]  T. Ahola,et al.  Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase , 2009, Proceedings of the National Academy of Sciences.

[25]  Joy Y. Feng,et al.  The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus , 2020, The Journal of Biological Chemistry.

[26]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[27]  S. Demo,et al.  Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. , 2005, Blood.

[28]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[29]  Tongqing An,et al.  The updated analysis of African swine fever virus genomes: two novel genotypes are identified. , 2020, The Journal of infection.

[30]  Genji Kurisu,et al.  The Biological Structure Model Archive (BSM-Arc): an archive for in silico models and simulations , 2020, Biophysical Reviews.

[31]  K. Inagaki,et al.  Antiviral effect of sinefungin on in vitro growth of feline herpesvirus type 1 , 2019, The Journal of Antibiotics.

[32]  Jingze Liu,et al.  Tick-borne pathogens and the vector potential of ticks in China , 2015, Parasites & Vectors.

[33]  Jianjun Gao,et al.  Discovering drugs to treat coronavirus disease 2019 (COVID-19). , 2020, Drug discoveries & therapeutics.

[34]  J. Sánchez-Vizcaíno,et al.  African swine fever virus transmission cycles in Central Europe: Evaluation of wild boar-soft tick contacts through detection of antibodies against Ornithodoros erraticus saliva antigen , 2016, BMC Veterinary Research.

[35]  J. Vincent,et al.  A PILOT-CONTROLLED STUDY OF A POLYMYXIN B-IMMOBILIZED HEMOPERFUSION CARTRIDGE IN PATIENTS WITH SEVERE SEPSIS SECONDARY TO INTRA-ABDOMINAL INFECTION , 2005, Shock.

[36]  V. Myneedu,et al.  Microscopy as a diagnostic tool in pulmonary tuberculosis. , 2015, International journal of mycobacteriology.

[37]  T. Walsh,et al.  Amino Acid Metabolism and Transport Mechanisms as Potential Antifungal Targets , 2018, International journal of molecular sciences.

[38]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[39]  Christopher Gilpin,et al.  WHO's new End TB Strategy , 2015, The Lancet.

[40]  E. Holmes,et al.  Homologous Recombination Is Very Rare or Absent in Human Influenza A Virus , 2008, Journal of Virology.

[41]  Wen J. Li,et al.  Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation , 2015, Nucleic Acids Res..

[42]  Gerhard Klebe,et al.  DSX: A Knowledge-Based Scoring Function for the Assessment of Protein-Ligand Complexes , 2011, J. Chem. Inf. Model..

[43]  D. Irwin,et al.  Phylogeographic patterns of the African swine fever virus. , 2019, The Journal of infection.

[44]  Yun Zhang,et al.  ViPR: an open bioinformatics database and analysis resource for virology research , 2011, Nucleic Acids Res..

[45]  Samer I. Al-Gharabli,et al.  Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease , 2011, Antiviral Research.

[46]  S. Ladhani,et al.  Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab , 2017, Pediatrics.

[47]  P. Sanseau,et al.  Drug repurposing: progress, challenges and recommendations , 2018, Nature Reviews Drug Discovery.

[48]  Tsuyoshi Shirai,et al.  Classification of ligand molecules in PDB with fast heuristic graph match algorithm COMPLIG. , 2012, Journal of molecular biology.

[49]  D. Irwin,et al.  Rare homologous recombination in H3N2 avian influenza A viruses. , 2019, The Journal of infection.

[50]  M. Liao,et al.  Continuous adaptation of the HA and NA gene of H3N2 subtypes of avian influenza virus in South China, 2017-2018. , 2019, The Journal of infection.

[51]  H. Crooke,et al.  African Swine Fever: Disease Dynamics in Wild Boar Experimentally Infected with ASFV Isolates Belonging to Genotype I and II , 2019, Viruses.

[52]  John Camm,et al.  Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[53]  J. Bao,et al.  Infection of African swine fever in wild boar, China, 2018. , 2019, Transboundary and emerging diseases.

[54]  J. McCarthy,et al.  Safety and effectiveness of apheresis in the treatment of infectious diseases: a systematic review. , 2019, The Journal of infection.

[55]  Alexander E Gorbalenya,et al.  Mechanisms and enzymes involved in SARS coronavirus genome expression. , 2003, The Journal of general virology.

[56]  R. Kirkcaldy,et al.  Disseminated gonococcal infections in patients receiving eculizumab: a case series. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[58]  Leyi Wang,et al.  Epidemiological analysis of respiratory viral etiology for influenza-like illness during 2010 in Zhuhai, China , 2013, Virology Journal.

[59]  H. Attoui,et al.  Complete sequence characterization of isolates of Getah virus (genus Alphavirus, family Togaviridae) from China. , 2008, The Journal of general virology.

[60]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[61]  David J. Evans,et al.  Mechanisms and consequences of positive-strand RNA virus recombination. , 2018, The Journal of general virology.

[62]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[63]  Shoujun Li,et al.  Emergence of Getah Virus Infection in Horse With Fever in China, 2018 , 2019, Front. Microbiol..

[64]  D. Granoff,et al.  Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab , 2018, Emerging infectious diseases.

[65]  Guo-Wei Wei,et al.  Potentially highly potent drugs for 2019-nCoV , 2020, bioRxiv.

[66]  D. Posada.  Evaluation of methods for detecting recombination from DNA sequences: empirical data. , 2002, Molecular biology and evolution.

[67]  Jonathan H. Epstein,et al.  Bats Are Natural Reservoirs of SARS-Like Coronaviruses , 2005, Science.

[68]  Maureen H Diaz,et al.  Detection and Characterization of Mycoplasma pneumoniae during an Outbreak of Respiratory Illness at a University , 2013, Journal of Clinical Microbiology.

[69]  M. Kiupel,et al.  Molecular characterization of a novel coronavirus associated with epizootic catarrhal enteritis (ECE) in ferrets , 2006, Virology.

[70]  J. Epstein,et al.  Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor , 2013, Nature.

[71]  Y. Kanno,et al.  Newly Developed Immobilized Polymyxin B Fibers Improve the Survival of Patients with Sepsis , 2001, Blood Purification.

[72]  Susanna K. P. Lau,et al.  Coronavirus Genomics and Bioinformatics Analysis , 2010, Viruses.

[73]  Edward C Holmes,et al.  Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses. , 2003, The Journal of general virology.

[74]  Liming Yan,et al.  Structural basis and functional analysis of the SARS coronavirus nsp14–nsp10 complex , 2015, Proceedings of the National Academy of Sciences.

[75]  Shan Gao,et al.  DNA segments of African Swine Fever Virus detected for the first time in hard ticks from sheep and bovines , 2019, Systematic and Applied Acarology.

[76]  K. Dheda,et al.  Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results? , 2016, Clinical Infectious Diseases.

[77]  S. Weiss,et al.  Coronavirus polyprotein processing. , 1994, Archives of virology. Supplementum.

[78]  Kazuki Saito,et al.  KNApSAcK family databases: integrated metabolite-plant species databases for multifaceted plant research. , 2012, Plant & cell physiology.

[79]  M. James,et al.  Crystal Structures Reveal an Induced-fit Binding of a Substrate-like Aza-peptide Epoxide to SARS Coronavirus Main Peptidase , 2006, Journal of Molecular Biology.

[80]  David A. Steinhauer,et al.  Genetics of influenza viruses. , 2002 .

[81]  Ying Sun,et al.  Biochemical and Structural Insights into the Mechanisms of SARS Coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 Protein Complex , 2011, PLoS pathogens.

[82]  H. Chow,et al.  Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases , 2012, European Journal of Medicinal Chemistry.

[83]  M. Alfa,et al.  Validation of adenosine triphosphate to audit manual cleaning of flexible endoscope channels. , 2013, American journal of infection control.

[84]  Chuan Qin,et al.  From SARS to MERS, Thrusting Coronaviruses into the Spotlight , 2019, Viruses.

[85]  S. Dorman,et al.  Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study , 2018, The Lancet. Infectious diseases.

[86]  Arthur S Slutsky,et al.  Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target , 2020, Intensive Care Medicine.

[87]  L. Mascia,et al.  Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors , 2008, Intensive Care Medicine.

[88]  C. Qin,et al.  The importation of the phylogenetic-transition state of Zika virus to China in 2014. , 2018, The Journal of infection.

[89]  C. Sanoski,et al.  Tecadenoson: A Novel, Selective A1 Adenosine Receptor Agonist , 2005, Cardiology in review.

[90]  Yu Chen,et al.  Molecular mechanisms of coronavirus RNA capping and methylation , 2016, Virologica Sinica.

[91]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[92]  H. Gavras,et al.  INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILURE , 1978, The Lancet.

[93]  H. R. Evans,et al.  Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. , 2004, Biochemistry.

[94]  M. Hoehn,et al.  A9145, a new adenine-containing antifungal antibiotic. I. Discovery and isolation. , 1973, The Journal of antibiotics.

[95]  Carfilzomib , 2019, Reactions Weekly.

[96]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[97]  Jianjun Gao,et al.  Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. , 2020, Bioscience trends.

[98]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[99]  D. S. Albers,et al.  Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice , 2018, Investigative ophthalmology & visual science.

[100]  B. Murrell,et al.  RDP4: Detection and analysis of recombination patterns in virus genomes , 2015, Virus evolution.

[101]  M. Hoelscher,et al.  Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study. , 2018, The Journal of infection.

[102]  M. Ondetti.  From peptides to peptidases: a chronicle of drug discovery. , 1994, Annual review of pharmacology and toxicology.

[103]  K. Lole,et al.  Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination , 1999, Journal of Virology.

[104]  Edward C. Holmes,et al.  Guidelines for Identifying Homologous Recombination Events in Influenza A Virus , 2010, PloS one.

[105]  Hongzhou Lu,et al.  Drug treatment options for the 2019-new coronavirus (2019-nCoV). , 2020, Bioscience trends.

[106]  C. A. Stone,et al.  Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. , 1981, The Journal of pharmacology and experimental therapeutics.

[107]  Zhiyong Lu,et al.  A survey of current trends in computational drug repositioning , 2016, Briefings Bioinform..

[108]  Ali Masoudi-Nejad,et al.  Drug databases and their contributions to drug repurposing. , 2020, Genomics.

[109]  M. Kusunoki,et al.  Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors. , 2011, Journal of medicinal chemistry.

[110]  O. Mimoz,et al.  Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial , 2015, Intensive Care Medicine.

[111]  P. Daszak,et al.  Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin , 2018, Nature.

[112]  Andrej Sali,et al.  Comparative Protein Structure Modeling Using MODELLER , 2014, Current protocols in bioinformatics.

[113]  Ronald N. Jones,et al.  Determination of CEM-101 Activity Tested against Clinical Isolates of Neisseria meningitidis from a Worldwide Collection , 2010, Antimicrobial Agents and Chemotherapy.

[114]  Y. Teo,et al.  Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review , 2020, Journal of clinical medicine.

[115]  R. Hilgenfeld,et al.  Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors , 2020, Science.

[116]  Y. Fukunaga,et al.  Getah virus as an equine pathogen. , 2000, The Veterinary clinics of North America. Equine practice.

[117]  Haruki Nakamura,et al.  Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.

[118]  V. Wong,et al.  Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. , 2003, Hong Kong medical journal = Xianggang yi xue za zhi.

[119]  Philip M. Dean,et al.  Three-dimensional hydrogen-bond geometry and probability information from a crystal survey , 1996, J. Comput. Aided Mol. Des..

[120]  O. Pybus,et al.  Questioning the evidence for genetic recombination in the 1918 "Spanish flu" virus. , 2002, Science.

[121]  M. Pérez‐Losada,et al.  Recombination in viruses: Mechanisms, methods of study, and evolutionary consequences , 2014, Infection, Genetics and Evolution.

[122]  Gérard Bricogne,et al.  Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2′-O-Methyltransferase nsp10/nsp16 Complex , 2011, PLoS pathogens.

[123]  R. Abbasi,et al.  Natural products as reservoirs of novel therapeutic agents , 2018, EXCLI journal.

[124]  T. Nakamura,et al.  Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor 4 and β-thromboglobulin , 1999, Inflammation Research.

[125]  Saurabh Menon,et al.  ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis , 2004, Journal of Biological Chemistry.

[126]  Weiliang Zhu,et al.  Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation , 2020, bioRxiv.

[127]  P. Waldron,et al.  Unusual Neisseria species as a cause of infection in patients taking eculizumab. , 2019, The Journal of infection.

[128]  Y. Guan,et al.  Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings , 2004, Thorax.

[129]  Ming-hua Li,et al.  From discovery to spread: The evolution and phylogeny of Getah virus. , 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[130]  B. Li,et al.  [Study on seasonal characteristics and pathogenic distribution of influenza in Gansu province of China]. , 2017, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[131]  D. Irwin,et al.  The recombination hot spots and genetic diversity of the genomes of African swine fever viruses. , 2019, The Journal of infection.

[132]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[133]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[134]  D. van Soolingen,et al.  Performance of Xpert MTB/RIF Ultra: a matter of dead or alive. , 2018, The Lancet. Infectious diseases.

[135]  P. Blanchard,et al.  Antileishmanial Effect of Sinefungin and its Derivatives , 1989 .

[136]  Hsin-Jen Chen,et al.  Imported dengue fever and climatic variation are important determinants facilitating dengue epidemics in Southern Taiwan. , 2019, The Journal of infection.

[137]  Ute Roessner,et al.  A Historical Overview of Natural Products in Drug Discovery , 2012, Metabolites.

[138]  J. Jorgensen,et al.  Susceptibility of Neisseria meningitidis to 16 Antimicrobial Agents and Characterization of Resistance Mechanisms Affecting Some Agents , 2005, Journal of Clinical Microbiology.

[139]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[140]  B. Haagmans,et al.  Enteric Coronavirus in Ferrets, the Netherlands , 2011, Emerging infectious diseases.

[141]  J. Marshall,et al.  Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial , 2018, JAMA.

[142]  C. Ling.  Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) , 2020, Journal of Integrative Medicine.

[143]  I. Galindo,et al.  African Swine Fever Virus: A Review , 2017, Viruses.

[144]  Y. Tong,et al.  Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model , 2020, Chinese medical journal.